Carson Lisa Cabott
SEC CIK 2073513 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PHIO | Phio Pharmaceuticals Corp. | VP, Fin, Administration | 81.1K | — | — | 3 | 2025-09-11 | 2026-09-11 |
Transactions 3
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 16:00 | 2026-09-11 | PHIO | Phio Pharmaceuticals Corp. | Carson Lisa Cabott | CFO | F - Tax | $1.03 | -12.9K | 81.1K | -14% | -$13.3K | |
| 2026-02-06 | 2026-02-05 | PHIO | Phio Pharmaceuticals Corp. | Carson Lisa Cabott | CFO | A - Grant | $0.00 | +47.0K | 94.0K | +100% | $0 | |
| 2025-09-15 | 2025-09-11 | PHIO | Phio Pharmaceuticals Corp. | Carson Lisa Cabott | VP, Fin, Administration | A - Grant | $0.00 | +47.0K | 47.0K | New | $0 |